Do you provide DHT inhibition?
DHT inhibition testing: synthesis and signalling assays
Dihydrotestosterone is the most potent androgen acting on the hair follicle. In people whose follicles are sensitive to it, DHT signalling through the androgen receptor in dermal papilla cells is linked to a gradual shortening of the growth phase and finer hair. An ingredient can reduce this signal in two ways, and each has its own assay.
Blocking DHT formation
The 5α-reductase enzyme converts testosterone to DHT. The laboratory incubates the enzyme, or cells that express it, with testosterone and the test material, then quantifies the DHT formed. Concentration-response curves give an IC50 where the data support it. The dedicated follicular 5α-reductase study covers this route in detail.
Dampening the response to DHT
Dermal papilla cells or other androgen-responsive models are exposed to DHT with and without the ingredient. Depending on the question, the laboratory measures receptor binding in a dedicated binding experiment, activation of an androgen-responsive reporter gene, or expression of downstream genes that DHT normally switches on.
- DHT formed relative to vehicle and reference inhibitor
- Androgen-receptor reporter activity
- Downstream gene expression in dermal papilla cells
- Cell viability to exclude nonspecific effects
IC50, percentage inhibition and interference checks
The report specifies the enzyme source or cell model, the readout used for each route, IC50 or percentage inhibition at each concentration, control data, and checks for assay interference from the sample.
Applying DHT inhibition results in hair product development
DHT data is most useful when the study design follows the way your active is described to formulators.
Choosing the right route for your claim
If your active is described as a 5α-reductase inhibitor, the enzyme assay is the evidence you need. If it is described as reducing the follicle’s sensitivity to androgens, you need receptor or downstream gene data. Many suppliers run both so they can present the full profile and compare it with a known reference inhibitor.
From cell data to a finished scalp product
DHT inhibition is an early screening step. Promising actives move into isolated follicle culture, where hair growth efficacy testing shows whether the follicle keeps growing longer in the presence of androgen. Skin delivery work and a volunteer study on the formulated product follow. Products presented as acting on hormones can fall into a different regulatory category in some markets, so the claim wording is usually checked alongside the data.
Certificate of analysis, solvent and sample clean-up
Supply the active with a certificate of analysis, the solvent it dissolves in and the concentration range of interest. Extracts with strong colour or high lipid content can interfere with detection, so the lab may need to clean up samples before DHT analysis by immunoassay or LC-MS.
More in Hair Follicle & Fibre
Hair Follicle & Fibre studies test how an active works on the living follicle and the hair shaft: growth signals, androgens, keratin and pigment.









